Stay updated on BGB324 in Recurrent Glioblastoma Surgery Clinical Trial
Sign up to get notified when there's something new on the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page.

Latest updates to the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page
- Check6 days agoChange DetectedTermination notice for the ABTC Consortium with the official close date appears on the page, along with related update dates.SummaryDifference0.1%

- Check13 days agoChange DetectedA minor revision label update was made, adding v3.4.2 and removing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision metadata updated from v3.4.0 to v3.4.1. No changes to the study content or its reported outcomes.SummaryDifference0.1%

- Check27 days agoChange DetectedNew UI elements and minor text updates were implemented: a Show glossary toggle appears, the label 'Last Update Submitted that Met QC Criteria' is shown, capitalization for 'No FEAR Act Data' is standardized, and the footer now displays 'Revision: v3.4.0' (replacing v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a revision history update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed. No substantive changes were made to the study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded dedicated Locations sections listing participating sites by state (Alabama, Maryland, Michigan, New York, North Carolina, Pennsylvania) and updated the revision to v3.3.3. Removed the older state-location headings and the HHS Vulnerability Disclosure link, along with revision 3.3.2.SummaryDifference0.7%

Stay in the know with updates to BGB324 in Recurrent Glioblastoma Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BGB324 in Recurrent Glioblastoma Surgery Clinical Trial page.